Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein

International Journal of Infectious Diseases

Volumn 14, Issue 12, 2010, Pages

  Djawe, Kpandja ^a   Daly, Kieran R ^a   Vargas, Sergio L ^b   Santolaya, M Elena ^c   Ponce, Carolina A ^b   Bustamante, Rebeca ^b   Koch, Judith ^a   Levin, Linda ^a   Walzer, Peter D ^a,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Children; Major surface glycoprotein (Msg); Pneumocystis; Serological responses

Indexed keywords

GLYCOPROTEIN; RECOMBINANT PROTEIN;

ANTIBODY DETECTION; ARTICLE; CHILD; CHILE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; INFANT; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; SENSITIVITY ANALYSIS; SEROEPIDEMIOLOGY;

ANTIBODIES, FUNGAL; CHILD, PRESCHOOL; CHILE; FUNGAL PROTEINS; HUMANS; INFANT; MEMBRANE GLYCOPROTEINS; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECII; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES;

EID: 78649632424     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.07.003     Document Type: Article

References (46)

1. Walzer P.D., Smulian A.G. Pneumocystis species. Principles and practice of infectious diseases 2010, 3377-3407. Elsevier, Inc, Philadelphia. G.L. Mandell, R. Dolin, J.E. Bennett (Eds.).
2. Meuwissen J.H., Tauber I., Leeuwenberg A.D., Beckers P.J., Sieben M. Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis 1977, 136:43-49.
3. Pifer L.L., Hughes W.T., Stagno S., Woods D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978, 61:35-41.
4. Vargas S.L., Hughes W.T., Santolaya M.E., Ulloa A.V., Ponce C.A., Cabrera C.E., et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001, 32:855-861.
5. Peglow S.L., Smulian A.G., Linke M.J., Pogue C.L., Nurre S., Crisler J., et al. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis 1990, 161:296-306.
6. Stagno S., Pifer L.L., Hughes W.T., Brasfield D.M., Tiller R.E. Pneumocystis carinii pneumonitis in young immunocompetent infants. Pediatrics 1980, 66:56-62.
7. Nevez G., Totet A., Pautard J.C., Raccurt C. Pneumocystis carinii detection using nested-PCR in nasopharyngeal aspirates of immunocompetent infants with bronchiolitis. J Eukaryot Microbiol 2001, (Suppl):122S-123S.
8. Vargas S.L., Ponce C.A., Luchsinger V., Silva C., Gallo M., Lopez R., et al. Detection of Pneumocystis carinii f. sp. hominis and viruses in presumably immunocompetent infants who died in the hospital or in the community. J Infect Dis 2005, 191:122-126.
9. Larsen H.H., von Linstow M.L., Lundgren B., Hogh B., Westh H., Lundgren J.D. Primary Pneumocystis infection in infants hospitalized with acute respiratory tract infection. Emerg Infect Dis 2007, 13:66-72.
10. Walzer P.D. Immunological features of Pneumocystis carinii infection in humans. Clin Diagn Lab Immunol 1999, 6:149-155.
11. Garbe T.R., Stringer J.R. Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii. Infect Immun 1994, 62:3092-3101.
12. Kutty G., Kovacs J.A. A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci. Infect Immun 2003, 71:571-574.
13. Gigliotti F., Hughes W.T. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest 1998, 81:1666-1668.
14. Theus S.A., Andrews R.P., Steele P., Walzer P.D. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. J Clin Invest 1995, 95:2587-2593.
15. Theus S.A., Smulian A.G., Steel P., Linke M.J., Walzer P.D. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine 1998, 16:1149-1157.
16. Daly K.R., Koch J., Levin L., Walzer P.D. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis 2004, 10:848-854.
17. Daly K.R., Huang L., Morris A., Koch J., Crothers K., Levin L., et al. Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerg Infect Dis 2006, 12:1231-1237.
18. Tipirneni R., Daly K.R., Jarlsbert L.G., Koch J.V., Swartzman A., Roth B.M., et al. Healthcare worker occupation and immune response to Pneumocystis jirovecii. Emerg Infect Dis 2009, 15:1590-1597.
19. Daly K.R., Koch J.V., Shire N.J., Levin L., Walzer P.D. Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones. Clin Vaccine Immunol 2006, 13:1071-1078.
20. Daly K., Koch J., Respaldiza N., de la Horra C., Montes-Cano M.A., Medrano F.J., et al. Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens. Clin Microbiol Infect 2009, 15:937-942.
21. Walzer P.D., Djawe K., Levin L., Daly K.R., Koch J., Kingsley L., et al. Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection. J Infect Dis 2009, 199:1335-1344.
22. Sternberg J.M. Human African trypanosomiasis: clinical presentation and immune response. Parasite Immunol 2004, 26:469-476.
23. Hviid L. The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective. Parasite Immunol 2004, 26:477-486.
24. Kovacs J.A., Powell F., Edman J.C., Lundgren B., Martinez A., Drew B., Angus C.W. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J Biol Chem 1993, 268:604-640.
25. Stirnadel H.A., Beck H.P., Alpers M.P., Smith T.A. Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea. Genet Epidemiol 1999, 17:16-34.
26. Taylor R.R., Egan A., McGuinness D., Jepson A., Drakely C., Riley E. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int Immunol 1996, 8:905-915.
27. Vestergaard L.S., Lusingu J.P., Nielsen M.A., Mmbando B.P., Dodoo D., Akanmori B.D., et al. Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in Northeastern Tanzania. Infect Immun 2008, 76:2706-2714.
28. Stirnadel H.A., Al-Yaman F., Genton B., Alpers M.P., Smith T.A. Assessment of different sources of variation in antibody responses to specific malaria antigens in children in Papua New Guinea. Int J Epidemiol 2000, 29:579-586.
29. Nielsen M.A., Vestergaard L.S., Lusingu J., Kurtzhals J.A., Giha H.A., Grevstad B., et al. Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens. Infect Immun 2004, 76:3531-3535.
30. Booth M., Dunne D.W. Spatial awareness in parasite immuno-epidemiology. Parasite Immunol 2004, 26:499-507.
31. Vargas S.L., Pizarro P., Lopez-Vieyra M., Neira-Aviles P., Bustamante R., Ponce C.A. Pneumocystis colonization in older adults and diagnostic yield of single versus paired noninvasive respiratory sampling. Clin Infect Dis 2010, 50:e19-21.
32. Mossong J., Putz L., Schneider F. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg. Epidemiol Infect 2004, 132:1121-1127.
33. Smith T., Maire N., Dietz K., Killeen G.F., Vounatsou P., Molineaux L., et al. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am J Trop Med Hyg 2006, 75(2 Suppl):11-18.
34. Sutton A.J., Hope V.D., Mathei C., Mravcik V., Sebakova H., Vallejo F., et al. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. J Viral Hepat 2008, 15:809-816.
35. Beard C.D., Carter J.L., Keely S.P., Huang L., Pieniazek N.J., Moura I.N., et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000, 6:265-272.
36. Morris A., Kingsley L.A., Groner G., Lebedeva I.P., Bearch C.B., Morris K.A. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004, 18:793-798.
37. Nikinin S.W., Daly K.R., Walzer P.D., Ndzi E.S., Asonganyi T., Respaldiza N., et al. Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians. Acta Trop 2009, 112:219-224.
38. Hoover D.R., Graham N.M., Bacellar H., Schrager L.K., Kaslow R., Visscher B., et al. Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men. Am Rev Respir Dis 1991, 144:756-759.
39. Lubis N., Baylis D., Short A., Stebbing J., Teague A., Portsmouth S., et al. Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia. Postgrad Med J 2003, 79:164-166.
40. Calderon E., de la Horra C., Medrano F.J., Lopez-Suarez A., Montes-Cano M.A., Respaldiza N., et al. Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis 2004, 23:545-549.
41. Respaldiza N., Medrano F.J., Medrano A.C., Varela J.M., de la Horra C., Montes-Cano M., et al. High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect 2004, 10:1029-1031.
42. Miller R.F., Grant A.D., Foley N.M. Seasonal variation in presentation of Pneumocystis carinii pneumonia. Lancet 1992, 339:747-748.
43. Sing A., Schmoldt S., Laubender R.P., Heesemann J., Sing D., Wildner M. Seasonal variation of Pneumocystis jirovecii infection: analysis of underlying climatic factors. Clin Microbiol Infect 2009, 15:957-960.
44. Spencer L., Ukwu M., Alexander T., Valadez K., Liu L., Frederick T., et al. Epidemiology of Pneumocystis colonization in families. Clin Infect Dis 2008, 46:1237-1240.
45. Angeloni A., Heston L., Uccini S., Sirianni M.C., Cottoni F., Masala M.V., et al. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 1998, 177:1715-1718.
46. Ng E.K., Thompson S.A., Perez-Perez G.I., Kansau I., van der Ende A., Labigne A., et al. Helicobacter pylori heat shock protein A: serologic responses and genetic diversity. Clin Diagn Lab Immunol 1999, 6:377-382.